The Valley Desk

NCT01785849 · Interventional trial

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

Overall registry status Completed

Phase 3

Conditions Hyperparathyroidism, Secondary

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov